# A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo

> **NCT06625177** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Teva Branded Pharmaceutical Products R&D LLC** · enrollment: 38 (actual)

## Conditions studied

- Vitiligo

## Interventions

- **DRUG:** TEV-53408

## Key facts

- **NCT ID:** NCT06625177
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-11
- **Primary completion:** 2026-05-09
- **Final completion:** 2027-06-05
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06625177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06625177, "A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06625177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*